| High potency of a bivalent human VH domain in SARS-CoV-2 animal models W Li, A Schäfer, SS Kulkarni, X Liu, DR Martinez, C Chen, Z Sun, SR Leist, ... Cell 183 (2), 429-441. e16, 2020 | 122 | 2020 |
| Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection W Li, C Chen, A Drelich, DR Martinez, LE Gralinski, Z Sun, A Schäfer, ... Proceedings of the National Academy of Sciences 117 (47), 29832-29838, 2020 | 88 | 2020 |
| Potent neutralization of SARS-CoV-2 by human antibody heavy-chain variable domains isolated from a large library with a new stable scaffold Z Sun, C Chen, W Li, DR Martinez, A Drelich, DS Baek, X Liu, JW Mellors, ... MAbs 12 (1), 1778435, 2020 | 62 | 2020 |
| De novo biosynthesis of resveratrol by site-specific integration of heterologous genes in Escherichia coli X Liu, J Lin, H Hu, B Zhou, B Zhu FEMS microbiology letters 363 (8), fnw061, 2016 | 39 | 2016 |
| Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain Fc fusion protein in mice X Liu, A Drelich, W Li, C Chen, Z Sun, M Shi, C Adams, JW Mellors, ... Vaccine 38 (46), 7205-7212, 2020 | 32 | 2020 |
| Metabolic engineering of Escherichia coli to enhance shikimic acid production from sorbitol X Liu, J Lin, H Hu, B Zhou, B Zhu World Journal of Microbiology and Biotechnology 30, 2543-2550, 2014 | 19 | 2014 |
| Site-specific integration and constitutive expression of key genes into Escherichia coli chromosome increases shikimic acid yields X Liu, J Lin, H Hu, B Zhou, B Zhu Enzyme and Microbial Technology 82, 96-104, 2016 | 16 | 2016 |
| Structural details of monoclonal antibody m971 recognition of the membrane-proximal domain of CD22 J Ereño-Orbea, X Liu, T Sicard, I Kucharska, W Li, D Borovsky, H Cui, ... Journal of Biological Chemistry 297 (2), 2021 | 9 | 2021 |
| Developability Assessment of an Isolated CH2 Immunoglobulin Domain B Pastrana, S Nieves, W Li, X Liu, DS Dimitrov Analytical chemistry 93 (3), 1342-1351, 2020 | 8 | 2020 |
| Enhanced production of shikimic acid using a multi-gene co-expression system in Escherichia coli Xiang-Lei LIU, J LIN, Hai-Feng HU, B ZHOU, Bao-QuanZHU Chinese Journal of Natural Medicines 14 (4), 286-293, 2016 | 7 | 2016 |
| 白藜芦醇的药理作用及其微生物合成的研究进展 刘学珍， 林军， 刘向磊， 胡海峰， 朱宝泉 世界临床药物, 56-60, 2015 | 7 | 2015 |
| Effective killing of cells expressing CD276 (B7-H3) by a bispecific T cell engager based on a new fully human antibody X Liu, D Zhelev, C Adams, C Chen, JW Mellors, DS Dimitrov Translational Oncology 14 (12), 101232, 2021 | 6 | 2021 |
| Construction of Novel Bispecific Single-Domain Antibodies (BiSdAbs) with Potent Antiangiogenic Activities X Liu, T Sun, Q Ge, J Zhu Pharmaceutical Fronts 2 (1), e64-e76, 2020 | 6 | 2020 |
| Protocol for constructing large size human antibody heavy chain variable domain (VH) library and selection of SARS-CoV-2 neutralizing antibody domains C Chen, Z Sun, X Liu, W Li, DS Dimitrov STAR protocols 2 (3), 100617, 2021 | 4 | 2021 |
| Potent and broad neutralization of SARS-CoV-2 variants of concern (VOCs) including omicron sub-lineages BA. 1 and BA. 2 by biparatopic human VH domains C Chen, JW Saville, MM Marti, A Schäfer, MH Cheng, D Mannar, X Zhu, ... Iscience 25 (8), 2022 | 1 | 2022 |
| The reduced form of the antibody CH2 domain Z Xi, X Liu, R Lin, JD Persons, TV Ilina, W Li, DS Dimitrov, R Ishima Protein Science 30 (9), 1895-1903, 2021 | | 2021 |
| 莽草酸生产重组菌株的构建 林军， 刘向磊， 胡海峰， 周斌， 朱宝泉 中国医药工业杂志 47 (5), 537-542, 2016 | | 2016 |
| 革兰阴性菌磷脂酶 D 致病机制的研究进展 刘向磊， 林军， 胡海峰， 朱宝泉 世界临床药物 33 (10), 616-619, 2012 | | 2012 |
